Can a gentle energy device turn down fibromyalgia pain?
NCT ID NCT07769177
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This trial tests whether TECAR therapy, a non-invasive device that delivers energy to painful areas, can reduce pain in people with fibromyalgia. About 46 adults with fibromyalgia will receive either real or sham TECAR sessions twice a week for three weeks. Researchers will measure changes in pain, sleep quality, and quality of life to see if the therapy offers meaningful relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TECAR therapy, a device-based treatment using capacitive and resistive energy transfer to painful areas
- What this could lead to
- If effective, TECAR therapy could offer a drug-free option to reduce pain and improve sleep and daily function in people with fibromyalgia.
- What could go wrong
- This is a small early-stage trial, and the sham control may produce similar effects. Results may not apply to all fibromyalgia patients, and benefits could be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA (FM) OR FIBROMYALGIA SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Üniversiteler Mahallesi, Bilkent Caddesi, No: 1 (veya 6000. Cadde, No: 9) Çankaya Ankara Turkey
Ankara, 06, Turkey (Türkiye)